Honey shows no advantages compared to standard antibiotics in trial on patients with kidney failure

October 9, 2013

Applying medical grade honey to wound sites in patients undergoing peritoneal dialysis—a procedure used to clean the blood in patients with kidney failure—shows no advantages over standard antibiotic use, according to new results published in The Lancet Infectious Diseases.

The research, which is the first time has been tested as an in peritoneal dialysis, will disappoint clinicians who had hoped that honey might offer a better alternative to antibiotics for this procedure. Peritoneal dialysis is an important treatment for individuals with kidney failure, whereby a is inserted into the peritoneum (the thin membrane which surrounds the organs in the abdomen) and dialysis is used to clean the blood in the absence of functioning kidneys.

Worldwide, peritoneal dialysis is used in more than 200 000 annually with end-stage , but further uptake of the procedure has been limited due to the risks of , either at the site of catheter insertion, or of the peritoneum itself (peritonitis). This type of infection can have life-threatening consequences, and although it is usually treated with antibiotics, the types of antibiotics which are suitable for use in these circumstances are effective against only a narrow range of infections, and are increasingly contributing to .

Several trials and meta-analyses have suggested that medical grade honey – produced by comprehensively sterilising standard honey – is effective against a wider range of microorganisms than antibiotics typically used to prevent wound infections, and does not appear to contribute to antibiotic resistance. These promising properties led a team of researchers, led by Professor David Johnson at the Australasian Kidney Trials Network (The University of Queensland) and Princess Alexandra Hospital in Brisbane, Australia, to test the performance of honey applied daily to the wound site in patients receiving peritoneal dialysis against a standard antibiotic treatment applied nasally, mupirocin.

371 trial participants undergoing peritoneal dialysis were recruited from 26 different medical centres in Australia and New Zealand, with 186 patients receiving a daily application of 10mg of medical grade honey to the site of , alongside standard wound care. The remaining 185 patients were assigned to the control group, where they were tested for nasal carriage of S aureus, and treated with mupirocin plus standard care if they tested positive, and just standard wound care if S aureus could not be detected.

The researchers found no significant difference between the average time to first infection in the honey or control groups, with patients in the honey group having an average of 16 months until their first infection, and patients in the control group having an average of 17.7 months until their first infection. Furthermore, the results showed that for patients with diabetes, the time to first infection was significantly reduced in the honey group (11.6 months on average), and the risk of peritonitis was almost twice as high compared to patients with diabetes in the .

"While the fact that honey doesn't contribute to antibacterial resistance makes it an attractive option for preventing infection at wound sites, our results suggest that honey cannot be routinely recommended for the prevention of infections related to peritoneal dialysis," says Professor Johnson. "Not only do our results show that honey doesn't work any better than standard exit site care and additional nasal mupirocin for nasal carriage of S aureus in protecting peritoneal dialysis patients from infection, we had a high rate of withdrawal from the study in the honey group, usually at the request of the patient or physician. This suggests that patients may have found the daily application of honey to the wound site uncomfortable or inconvenient."

In a linked Comment, Professors Achim Jörres and Wim van Biesen point out that with rising rates of end stage renal disease worldwide, new research into the best options for peritoneal dialysis patients is to be welcomed. However, they suggest that the disappointing efficacy of honey in protecting against infection in this trial may not be entirely due to the properties of honey as an antibacterial agent, writing that, "Although the results of [this study] show the efficacy of mupirocin versus Medihoney, the important question of whether patients with a healthy catheter exit site for should receive prophylactic treatment remains to be addressed. In our view, and according to the principle of primum non nocere (first do no harm), the key to preservation of exit-site integrity is optimal catheter fixation and avoidance of unnecessary manipulations."

Explore further: Peritoneal dialysis as an intervention for stroke patients

More information: www.thelancet.com/journals/lan … (13)70258-5/abstract

Related Stories

Peritoneal dialysis as an intervention for stroke patients

September 3, 2013
Ischemic stroke is characterized by an interruption of the blood supply to the brain, which can lead to brain damage and even death. Excess amounts of the excitatory neurotransmitter glutamate are released during stroke events ...

Landmark study provides key to improved survival in peritoneal dialysis patients

September 23, 2013
Clinicians and scientists from Keele and Cardiff universities have published data from a landmark study that explains why survival in patients on peritoneal dialysis is low.

Infections may be deadly for many dialysis patients

May 24, 2012
An infection called peritonitis commonly arises in the weeks before many dialysis patients die, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings ...

Quality of life and treatment of late-stage chronic kidney disease

September 11, 2012
Renal transplantation is best treatment option for improving quality of life in people with late-stage chronic kidney disease

Surprising results for use of dialysis for kidney failure in developing world

April 26, 2012
Researchers at Lawson Health Research Institute have discovered that developing countries have faster growing rates of use of home-based dialysis (called peritoneal dialysis) for kidney failure than the developed world. Despite ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.